
Tirzepatide weight loss treatment is injected once a week to help you lose weight as part of a wider diet and exercise programme. It’s found under the brand name Mounjaro.
Tirzepatide is the first dual-action medication created in the drug classes of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists. It works by mimicking these hormones to control blood sugar levels, but research shows it also induces weight loss.
Tirzepatide is one of the few medications licensed in the UK for weight loss
What class of drug is tirzepatide?
Tirzepatide’s drug class is both a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. GIP and GLP-1 are hormones that occur naturally in your body. Tirzepatide works by imitating these 2 hormones to lower your blood sugar levels and appetite.
You may hear tirzepatide being referred to as a dual receptor agonist. It is the first drug in this class of medications to be approved and released for type 2 diabetes and weight management. Mounjaro is the brand name for tirzepatide for weight loss.
What is tirzepatide used for?
Tirzepatide works by reducing your appetite and slowing down the movement of food from the stomach to the small intestine. This process helps to leave you feeling fuller for longer, making it easier to reduce your calorie intake. For this reason, tirzepatide has been released as a medication for weight loss.
Tirzepatide is also approved for the treatment of type 2 diabetes. Tirzepatide lowers blood sugar levels by increasing the production of insulin and lowering the amount of sugar your liver makes.